In March 2025, the company announced new programs for the immediate-to-purchaser providing of its Wegovy weight loss drug. The company recognized a completely new pharmacy, known as NovoCare, which would charge shoppers $499 every month for access to the drug, lower than fifty percent the cost of the drug through other pharmaceutical distribution n